Announcement

Collapse
No announcement yet.

Long-term outcomes of nonmyeloablative autologous HSCT in MS

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Long-term outcomes of nonmyeloablative autologous HSCT in MS

    These results are only in PDF form, the link is below. -D

    Long-term outcomes of nonmyeloablative autologous hematopoietic stem cell transplantation in multiple sclerosis

    I. Nikolaeva, D. Fedorenkob, O. Vinogradova, A. Kuznetsovc

    High-dose immunosuppressive therapy (HDIT) with autologous hematopoietic stem cell transplantation (AHSCT) is a new effective method of treatment of aggressive multiple sclerosis.

    ABSTRACT in PDF Form:

    https://www.jns-journal.com/article/...19)31316-4/pdf
    Dave Bexfield
    ActiveMSers
Working...
X